Searched for
SERUM INSTITUTE
Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI fundingSerum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fres...- Moderna and other groups get $60 million to develop Ebola vaccineCEPI is investing around $60 million to speed up the creation of vaccines against the deadly Ebola Bundibugyo virus. This funding will supp...
- What to know about the Bundibugyo virus, a species of Ebola causing an outbreak in CongoA rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...
- Ebola at the gates: Why India must not let its guard downIndia is enhancing its surveillance protocols following an Ebola outbreak in the Democratic Republic of Congo and Uganda. One of two suspec...
- Ebola vaccine update: Russia claims a breakthrough; Oxford researchers, Serum Institute of India aim to begin trial in 3 monthsA new Ebola vaccine developed by Russian scientists shows promise against the current outbreak strain in the Democratic Republic of Congo. ...
- IPL may become the GOAT of sports world; League sees sharp rise in valuations on record media rights deals, deep-pocketed sponsorsIPL franchise values are soaring, projected to hit $15 billion by 2032. This growth rivals top European football clubs. Record media rights...
- Rajasthan Royals sold for $1.65B to Mittal-Poonawalla consortiumA consortium led by the Mittal family and including Adar Poonawalla will acquire Rajasthan Royals for $1.65 billion. The Mittal family will...
- Oxford University strikes new malaria vaccine pact with Serum Institute of IndiaOxford University and Serum Institute of India are collaborating on a new malaria vaccine, R78C. This partnership aims to create a more eff...
- ET Awards: Cyrus Poonawalla reflects on SII’s mission of affordable vaccines and saving lives worldwideCyrus Poonawalla began Serum Institute of India in 1966 with a goal to make India self-reliant in healthcare. His vision was to provide aff...
- ET Awards: Star power to light up the night; Finance Minister Sitharaman to honour Chandrababu Naidu, India IncMumbai's Jio World Convention Centre hosts the 26th Economic Times Awards for Corporate Excellence, celebrating India's economic leaders. F...
- Startups, not the only game in townIndia faces a job creation challenge as millions enter the workforce. The nation needs to support entrepreneurship in key sectors like infr...
- Poonawalla's clear shot at access for all via route socialCyrus S Poonawalla, chairman of Serum Institute of India, has created a legacy where business and social impact go hand in hand. His vaccin...
- Funding for innovations key for India to remain vaccine leader: Cyrus PoonawallaSpeaking to ET after receiving the Lifetime Achievement Award for 2025 as part of the ET Awards for Corporate Excellence, Cyrus Poonawalla,...
- NTAGI to review trial data on SII's qHPV vaccine against cervical cancerSerum Institute of India Director for Government and Regulatory Affairs Prakash Kumar Singh applied to the Drugs Controller General of Indi...
- Govt allows Serum Institute to export 50 lakh Covishield doses under COVAX to four nationsSII will commence Covid vaccine export under the COVAX programme from November 23 and Nepal will receive the first lot of Covishield on Nov...
- Govt asks Serum Institute, Bharat Biotech to lower price of COVID-19 vaccines: Official sourcesThe Pune-based Serum Institute of India (SII), the world's largest vaccine maker in terms of volume, has announced a price of Rs 400 per do...
- Bombay HC rules in favour of Serum Institute in the trademark dispute for CovishieldA division bench of Justices Nitin Jamdar and C V Bhadang dismissed an appeal filed by pharmaceutical firm Cutis Biotech claiming trademark...
- 5 dead in Serum Institute fire; Covishield facility unaffectedThe building where the fire broke out is part of the under-construction site of the Serum facility and is one km from the Covishield manufa...
- Serum Institute rejects charges levelled by vaccine trial participant, will seek Rs 100 crore in damagesA 40-year-old man who took part in the 'Covidshield' vaccine trial in Chennai has alleged serious side effects, including a virtual neurolo...
- Serum Institute buys 3 lakh shares of Panacea for Rs 3.7 crVaccine firm Serum Institute of India today purchased about three lakh shares of Panacea Biotec for Rs 3.71 crore through open market trans...
Load More
